MX2013014006A - Metodo para la identificacion de ligandos de proteinas agregadas lamina beta. - Google Patents

Metodo para la identificacion de ligandos de proteinas agregadas lamina beta.

Info

Publication number
MX2013014006A
MX2013014006A MX2013014006A MX2013014006A MX2013014006A MX 2013014006 A MX2013014006 A MX 2013014006A MX 2013014006 A MX2013014006 A MX 2013014006A MX 2013014006 A MX2013014006 A MX 2013014006A MX 2013014006 A MX2013014006 A MX 2013014006A
Authority
MX
Mexico
Prior art keywords
beta
identification
protein ligands
aggregated protein
sheet
Prior art date
Application number
MX2013014006A
Other languages
English (en)
Inventor
Fiona Grueninger
Edilio Borroni
Christian Czech
Arnulf Dorn
Luca Gobbi
Valerie Goetschy-Meyer
Doris Roth
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2013014006A publication Critical patent/MX2013014006A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

La presente invención proporciona un ensayo para la identificación de ligandos de proteína agregadas de lámina beta usando rojo de tiazina R.
MX2013014006A 2011-06-22 2012-06-19 Metodo para la identificacion de ligandos de proteinas agregadas lamina beta. MX2013014006A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170878 2011-06-22
PCT/EP2012/061621 WO2012175458A1 (en) 2011-06-22 2012-06-19 A method for the identification of beta-sheet aggregated protein ligands

Publications (1)

Publication Number Publication Date
MX2013014006A true MX2013014006A (es) 2014-03-12

Family

ID=46320974

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014006A MX2013014006A (es) 2011-06-22 2012-06-19 Metodo para la identificacion de ligandos de proteinas agregadas lamina beta.

Country Status (10)

Country Link
US (1) US20140363898A1 (es)
EP (1) EP2724161A1 (es)
JP (1) JP2014520270A (es)
KR (1) KR20140026565A (es)
CN (1) CN103649757A (es)
BR (1) BR112013031498A2 (es)
CA (1) CA2837957A1 (es)
MX (1) MX2013014006A (es)
RU (1) RU2013158623A (es)
WO (1) WO2012175458A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11254718B2 (en) 2019-09-04 2022-02-22 Amprion, Inc. Alpha-synuclein substrates and methods for making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101385722A (zh) * 2003-02-27 2009-03-18 乔安妮·麦克劳林 预防、治疗和诊断蛋白聚集疾病的方法
AU2004252182A1 (en) * 2003-06-27 2005-01-06 Proteome Systems Ltd Method of isolating a protein

Also Published As

Publication number Publication date
CN103649757A (zh) 2014-03-19
CA2837957A1 (en) 2012-12-27
RU2013158623A (ru) 2015-07-27
BR112013031498A2 (pt) 2017-05-30
EP2724161A1 (en) 2014-04-30
WO2012175458A1 (en) 2012-12-27
US20140363898A1 (en) 2014-12-11
JP2014520270A (ja) 2014-08-21
KR20140026565A (ko) 2014-03-05

Similar Documents

Publication Publication Date Title
MX2013009362A (es) Anticuerpo contra el csf-1r.
WO2013086512A3 (en) Muscle chips and methods of use thereof
MX342240B (es) Anticuerpos anti-fgfr4 y metodos de uso.
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
UY34456A (es) Anticuerpos anti-il-36r
UY34394A (es) Polipéptidos de anticuerpos que antagonizan cd40l
IN2014DN10428A (es)
MA34091B1 (fr) Anticorps anti-cd40
MX2014004022A (es) Anticuerpos anti-htra1 y metodos de uso.
GB201103836D0 (en) Conjugation process
MX2012010853A (es) Anticuerpos anti-lrp6.
PH12015501059A1 (en) Anti-hemagglutinin antibodies and methods of use
EP3491017A4 (en) METHODS OF IDENTIFYING ANTIBODIES BLOCKING LILRB RECEPTORS
WO2012166626A8 (en) Reagents and methods for treating dental disease
UA117565C2 (uk) Модифікований олігонуклеотид
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
UY34527A (es) ?composiciones, métodos y kits para la preparación de proteínas recombinantes sialiladas?.
MX354303B (es) Anticuerpos de anti-biotina y metodos de uso.
MX370649B (es) Proceso para la preparacion de teneligliptina.
MX2015003541A (es) Metodos para identificar los anticuerpos con inmunogenia reducida.
WO2012047941A3 (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
MX2023006416A (es) Anticuerpos, usos y metodos.
UY4153Q (es) Batería
IN2014DN09450A (es)
MY166058A (en) Method for preparation of medetomidine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal